In prostate cancer on the other hand, treatment with NAC was reported to decrease ROS levels in Nkx3.1 mutant mouse prostates, but actually increase epithelial cell proliferation and expression of a pro-proliferative gene signature [53]. The gene discussed is NKX3-1; the disease is prostate carcinoma.